These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 882897)

  • 21. [Cellular immunity in lymphocytic leukemia].
    Iavorkovskiĭ LI; Sused SG
    Probl Gematol Pereliv Krovi; 1977 May; 22(5):12-5. PubMed ID: 877035
    [No Abstract]   [Full Text] [Related]  

  • 22. [Delayed hypersensitivity intracutaneous test with dinitrochlorobenzene (DNCB)].
    Grigorovich NA; Martysiuk TI; Monastyrnaia PL
    Vopr Onkol; 1979; 25(7):94-5. PubMed ID: 483690
    [No Abstract]   [Full Text] [Related]  

  • 23. [Correlation of the level of humoral cytotoxins and delayed hypersensitivity skin reactions with survival of patients with melanoma of the skin].
    Korosteleva TA; Vagner RI; Veresova OV; Potapenkova LS
    Vopr Onkol; 1983; 29(4):38-40. PubMed ID: 6858049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytology of delayed hypersensitivity reaction in patients with malignant tumors.
    Jansa P; Jorda V; Sternberský J
    Neoplasma; 1976; 23(1):119-20. PubMed ID: 1272470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A guinea pig model for tumor immunology. A summary.
    Rapp HJ
    Isr J Med Sci; 1973 Mar; 9(3):366-74. PubMed ID: 4122812
    [No Abstract]   [Full Text] [Related]  

  • 26. [Evaluation of immune status in a surgical milieu. Correlation and complementarity of DNCB and multipuncture apropos of 101 patients].
    Champault G; Lesaget F; Biron G; Defayolle M; Roumiantzeff M; Boutelier P
    Med Chir Dig; 1982; 11(1):9-12. PubMed ID: 7087578
    [No Abstract]   [Full Text] [Related]  

  • 27. [Controlled study of unspecific cellular immunity in cancer patients].
    Dominioni L; Dionigi R; Prati U; Cividini F; Cincera M; Pavesi L; Della Cuna GR
    Minerva Med; 1981 Mar; 72(12):733-40. PubMed ID: 6971418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor-specific immunity and the Otolaryngologist.
    Neel HB; Ritts RE
    Ann Otol Rhinol Laryngol; 1973; 82(3):323-9. PubMed ID: 4576262
    [No Abstract]   [Full Text] [Related]  

  • 29. Prognostic significance of cutaneous anergy for the surgical treatment of solid neoplasms.
    Morton DL; Eilber FR
    Natl Cancer Inst Monogr; 1971 Dec; 34():103-8. PubMed ID: 5140859
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cellular immunity in the neoplastic patient (preliminary note)].
    García-Sancho Martin L; Durán Sacristán M; García Blanco A; Conde Salazar L
    Rev Clin Esp; 1975 Nov; 139(3):275-6. PubMed ID: 1197852
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunological diagnosis of malignant diseases outside the lymphoreticular system].
    Wiig JN
    Tidsskr Nor Laegeforen; 1978 Sep; 98(25):1197-1200. PubMed ID: 358487
    [No Abstract]   [Full Text] [Related]  

  • 32. Delayed cutaneous hypersensitivity reactions to tumor cell antigens and to nonspecific antigens. Prognostic significance in patients with lung cancer.
    Wells SA; Burdick JF; Joseph WL; Christiansen CL; Wolfe WG; Adkins PC
    J Thorac Cardiovasc Surg; 1973 Oct; 66(4):557-62. PubMed ID: 4755446
    [No Abstract]   [Full Text] [Related]  

  • 33. Invited discussion: relationship of titers of Epstein-Barr virus to cell-mediated immunity in patients with Hodgkin's disease.
    Levine PH; Reisher JI
    Natl Cancer Inst Monogr; 1973 May; 36():85-7. PubMed ID: 4355354
    [No Abstract]   [Full Text] [Related]  

  • 34. A possible role for cross-reacting antigens in conditioning immunological surveillance mechanisms in cancer and transplantation. II. Prospective studies of altered cellular immune reactivity in cancer patients.
    Rapaport FT; Lawrence HS
    Transplant Proc; 1975 Jun; 7(2):281-5. PubMed ID: 1129846
    [No Abstract]   [Full Text] [Related]  

  • 35. In vivo methods for the assessment of cell-mediated tumor immunity.
    Bartlett GL
    Natl Cancer Inst Monogr; 1972 Dec; 35():27-32. PubMed ID: 4659049
    [No Abstract]   [Full Text] [Related]  

  • 36. [Some problems of immunological reactivity in patients with neoplasms].
    Zajaczkowski J
    Wiad Lek; 1976 Nov; 29(22):2009-12. PubMed ID: 1007268
    [No Abstract]   [Full Text] [Related]  

  • 37. A study of host defence reaction of breast carcinoma and its correlation with generalised delayed hypersensitivity.
    Nagar R; Maheshwari HB; Mukerjee P; Mittal MM
    Indian J Cancer; 1978 Sep; 15(3):63-8. PubMed ID: 757408
    [No Abstract]   [Full Text] [Related]  

  • 38. Tumor spread and reactivity to DNCB: (2, 4 Dinitro-1 chlorobenzene) skin test.
    el-Domeiri AA
    Int Surg; 1972 Aug; 57(8):617-9. PubMed ID: 5051760
    [No Abstract]   [Full Text] [Related]  

  • 39. Abnormal dinitrochlorobenzene skin sensitization: a prognostic sign of survival in head and neck squamous cell carcinoma.
    Maisel RH; Ogura JH
    Laryngoscope; 1973 Dec; 83(12):2012-9. PubMed ID: 4772104
    [No Abstract]   [Full Text] [Related]  

  • 40. D.N.C.B. testing in cancer patients.
    Yajnik CS; Mehta MJ; Sainani GS
    J Assoc Physicians India; 1982 Sep; 30(9):605-7. PubMed ID: 7184926
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.